Navigation Links
Global Apoptosis Industry
Date:11/8/2011

ent for MiCK (Microculture Kinetic)

Assay 30

Gloucester Pharma Intends to Discuss About New Drug

Application for Romidepsin 30

Cleveland BioLabs, Inc. Receives First Patent In the US 30

Daiichi Sankyo Commences Phase II Clinical Trials of CS-1008 31

5. RECENT INDUSTRY ACTIVITY 32

Cephalon to Take Over Gemin X 32

Amarantus BioSciences Enters into Licensing Agreement with

Generex Biotechnology 32

Celgene Takes Over Gloucester Pharmaceuticals 32

Sanofi Signs Research and Development Agreement with Ascenta 33

BIOCIUS Life Sciences Collaborates with BlueSky Biotech for

Providing Validated Enzymes 33

Ascenta Therapeutics Signs Agreement with Leukemia & Lymphoma

Society 33

Ascenta Therapeutics Collaborates with Ascentage Pharma Group 34

Aposense and Roche Ink Collaboration Agreement 34

Conatus Takes Over Idun 34

Cancer Research Technology Enters into Licensing Deal with ValiRx 35

Scancell Holdings Signs Licensing Agreement with University of

Nottingham 35

D-Pharm Collaborates with Wanbang Biopharmaceuticals 35

ACEA Biosciences, Roche and Vivo Biosciences Enter into

Collaboration 36

Infinity and Mundipharma Enter Into Global Alliance 36

Sigma-Aldrich and Highlands Stable Isotope Corporation Enter

into an Agreement 36

EntreMed, Inc. Enters Into Security Purchase Agreement with

Group of Strategic Investors 36

IBA Signs Collaboration Agreement with Aposense 37

Clinical Data and CombinatoRx Sign Partnership and Licensing

Agreement 37

FASgen and Centocor Ink Research and License Agreement 38

Graceway Pharmaceuticals Obtains Global Rights for GS 9191

Molecule 38

Æterna Zentaris Signs an Agreement with Sanofi-Aventis 38

6. FOCUS ON SELECT PLAYERS 39

Abbott Laboratories (USA) 39

AbGenomics International,
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Global Biochip Markets: Microarrays and Lab-on-a-Chip
2. Eppendorf AG Deploys a Strategic Information Management Solution on a Global Level
3. Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
4. Informex Introduces a Thorough Global Pharma Perspectives Conference
5. Global Automated And Rapid Microbiological Tests Industry
6. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo
7. United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report
8. Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations
9. Nanobiotechnology: Applications and Global Markets
10. Breakthrough in Preventing Food-borne Illnesses Wins $20,000 Grand Prize in Global Design Contest
11. Global Biotechnology Instrumentation Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Freeslate, Inc ., ... announced that Lupin Limited, one of India’s top five ... Protégé PharmD System for high throughput solid form ... focused on a wide range of quality, affordable generic ...
(Date:1/14/2014)... Diego, CA (PRWEB) January 14, 2014 ... on the products of cells grown under simulated embryonic ... international license agreement with Suneva Medical, Inc. for physician-dispensed ... (CCM). , This agreement is an amendment ...
(Date:1/14/2014)... Md. , Jan. 14, 2014  Organovo announced today ... the National Institutes of Health (NIH) to help scientists ... treatments to patients on a faster timeline. Organovo is ... (NCATS) and the National Eye Institute (NEI) to develop ...
(Date:1/14/2014)... , Jan. 14, 2014   Kinaxis ®, provider of ... and sales and operations planning ( S&OP ) service, is ... Summit , which will be held at the Hilton San ... join Kinaxis customer Elisabeth Kaszas , Director of Supply ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... launch product immediately, NATICK, Mass., April 17 ... announced that it has received approval for,the sale ... Canada. The Company reported that Health Canada,s Therapeutic,Products ... medical devices, has approved its use. The Company ...
... Syngenta today,announced that it will build a new biotech ... be on early-stage evaluation of GM and,native traits for ... areas of yield,improvement, drought resistance, disease control and biomass ... scope and will complement,Syngenta,s biotech research activities in the ...
... NexGenix Pharmaceuticals, presented,data on its Hsp90 inhibitor ... AACR,in San Diego today. The company presented data ... several novel, radicicol-based,Hsp90 inhibitors in its compound series., ... xenograft models,without evidence for liver and kidney toxicity. ...
Cached Biology Technology:Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System 2Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System 3Syngenta To Build Major Global Biotech Research Center in Beijing, China 2Syngenta To Build Major Global Biotech Research Center in Beijing, China 3NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect 2NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect 3
(Date:4/18/2014)... to the story of how barnyard chickens came to be, ... journal Proceedings of the National Academy of Sciences . ... 200-2300 years ago in Europe, researchers report that just a ... different from the chickens we know today. , The results ... domestic chickens -- such as their yellowish skin -- only ...
(Date:4/17/2014)... under clinical trials to treat tuberculosis could be the ... against various bacteria, fungal infections and parasites, yet evade ... chemists and collaborators. , Led by U. of I. ... ways the drug SQ109 attacks the tuberculosis bacterium, how ... from yeast to malaria and how targeting multiple ...
(Date:4/17/2014)... consumption advisories for expecting mothers are ineffective in ... organic pollutants (POPs). , The study, performed ... Toronto Scarborough PhD student Matt Binnington and Professor ... environmental contamination, a mother,s compliance with advisories, and ... exposure in her children. , Their model estimates ...
Breaking Biology News(10 mins):Ancient DNA offers clues to how barnyard chickens came to be 2Multitarget TB drug could treat other diseases, evade resistance 2Fish consumption advisories fail to cover all types of contaminants 2
... patients, own immune cells to target tumors have yielded promising ... also receive large doses of drugs designed to help immune ... Now a team of MIT engineers has devised a ... the backs of the cells sent in to fight the ...
... expensive DNA sequencing strategy, scientists have discovered genetic alterations ... rare disorder that causes multiple birth defects and mental ... new approach sequences just the exome, the 1-2 percent ... Kabuki syndrome, which has an estimated incidence of ...
... Stanley, Inc. (NYSE: www.stanleyassociates.com for ... this press release about our expectations about future ... the words "estimates," "anticipates," "plans," "expects" and similar ... the Private Securities Litigation Reform Act of 1995. ...
Cached Biology News:Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells 2Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells 3Discovered gene causes Kabuki syndrome 2Discovered gene causes Kabuki syndrome 3
Anti-Human Complement Component C4c, IgY fraction (Polyclonal) (chicken IgY)...
... 15 (KLF15) KLF15 is a Cys2-His2 ... expressed in the liver, kidneys, heart, and ... Specificity: Polyclonal antibody produced in rabbits immunized ... region of human KLF15 with an internal ...
... to introduce its new line of Protein ... proteins for use in mass spectrometry, molecular ... Protein Standards are high quality purified proteins ... analyses by electrospray ionization mass spectrometry (ESI-MS). ...
... N-Dodecyl-N,N-(dimethylammonio)butyrate White crystalline solid. ... to DDMAU (Cat. No. 252005) but differing ... More efficient for the extraction of mycoplasma ... Purity: ≥98% by TLC. Soluble ...
Biology Products: